➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Mallinckrodt
AstraZeneca
McKesson
Medtronic

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 8,741,847

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,741,847
Title:Agent and methods for reducing inflammatory markers
Abstract: A method for treating an autism spectrum condition includes administering an effective dose of a TNF-.alpha. inhibiting agent to a person having an autism spectrum condition or pervasive development disorder and at least one of elevated TNF-.alpha. in the cerebrospinal fluid or elevated TNF-.alpha. in the serum, as compared to normal conditions; and lowering at least one of the elevated TNF-.alpha. in the cerebrospinal fluid or elevated TNF-.alpha. in the serum. A TNF-.alpha. inhibiting agent includes at least one of Lenalinomide; Thalidomide; L-Carnosine; Infliximab; Etanercept; a stem cell preparation; derivatives thereof, isomers thereof, or pharmaceutically acceptable salts thereof.
Inventor(s): Chez; Michael (Granite City, CA)
Assignee:
Application Number:13/463,851
Patent Claims:see list of patent claims

Details for Patent 8,741,847

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 1998-08-24 ⤷  Try it Free 2029-11-06
Immunex Corporation ENBREL etanercept For Injection 103795 1998-11-02 ⤷  Try it Free 2029-11-06
Immunex Corporation ENBREL etanercept For Injection 103795 1999-05-27 ⤷  Try it Free 2029-11-06
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Baxter
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.